MedPath

Research for the Clinical Effect and Immune Mechanism of Soothing the Lung and Anti-fever, Resolving Blood-stasis and Unblocking Collaterals in the Treatment of Mycoplasma Pneumoniae Pneumonia in Childre

Not Applicable
Not yet recruiting
Conditions
Mycoplasma Pneumoniae Pneumonia
Registration Number
ITMCTR1900002294
Lead Sponsor
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Mycoplasma pneumoniae pneumonia in children meets the western medical diagnostic criteria;
2. Thermal process>48h and<96h;
3. The cough is prominent and persistent,and graded=2;
4. Peripheral white blood cell (WBC)count was normal;
5. It conforms to the TCM syndrome standard of wind-heat closed the lung or poison-heat closed the lung;
6. The children are aged 5~14;
7. The informed consent process is in compliance with regulations,the legal representative of the children signed the informed consent files.

Exclusion Criteria

1. For children with severe pneumonia, segmental or lobar parenchymal infiltration shadow similar to that of bacterial pneumonia can be clearly diagnosed as bacterial pneumonia or viral pneumonia, and simple hilar lymphadenoma with large through the chest X-ray manifestations;
2. Those who have used macrolide antibiotics and hormones before enrollment;
3. Confirmed mycoplasma pneumoniae infection in the past 3 months;
4. Pulmonary complications, including pleural effusion or empyema, pneumothorax, pulmonary abscess, bronchopleural fistula, necrotizing pneumonia, and acute respiratory failure, have occurred;
5. Pulmonary infection caused by primary immunodeficiency disease, acquired immunodeficiency syndrome, congenital respiratory tract malformation, abnormal lung development, aspiration pneumonia, lung malignancy and other basic diseases;
6. Patients with severe malnutrition, rickets and severe primary diseases of heart, brain, liver, kidney and hematopoietic system;
7. Allergic constitution (allergic to more than 2 kinds of substances), or allergic to macrolide antibiotics and components of jinzhen oral liquid;
8. According to the researcher's judgment, those who are not suitable for enrollment.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.